“SGLT2 Inhibitor-Associated Diabetic Ketoacidosis in a Pediatric Patient: An Off- Label Use Case Report”
Bashair Fahad Aldossari,1 Sheikhah Aldossari2 1Clinical Pharmacy Department, Ministry of Health, Riyadh, Saudi Arabia; 2Department of Medicine, Prince Sattam bin Abdulaziz University, Al-Kharj, 11942, Saudi ArabiaCorrespondence: Sheikhah Aldossari, Email Sheikhah96@gmail.comAbstract: A 7-year-old bo...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-08-01
|
| Series: | International Medical Case Reports Journal |
| Subjects: | |
| Online Access: | https://www.dovepress.com/sglt2-inhibitor-associated-diabetic-ketoacidosis-in-a-pediatric-patien-peer-reviewed-fulltext-article-IMCRJ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Bashair Fahad Aldossari,1 Sheikhah Aldossari2 1Clinical Pharmacy Department, Ministry of Health, Riyadh, Saudi Arabia; 2Department of Medicine, Prince Sattam bin Abdulaziz University, Al-Kharj, 11942, Saudi ArabiaCorrespondence: Sheikhah Aldossari, Email Sheikhah96@gmail.comAbstract: A 7-year-old boy presented with new-onset type one diabetes mellitus (T1DM) and moderate diabetic ketoacidosis (DKA). The patient presented with polyuria, polydipsia, and weight loss along with reduced activity and excessive sleepiness. Initial blood tests revealed elevated blood glucose levels, high anion-gap metabolic acidosis, and ketonuria. The patient was treated with fluid resuscitation, insulin infusion, and electrolyte replacement, which resolved within three days. During medication reconciliation, the patient was administered empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, by a family member without medical supervision. This case highlights the challenges in managing pediatric diabetes, potential risks of unauthorized medication use, and need for comprehensive family education in diabetes care. This also raises questions regarding the safety and benefits of SGLT2 inhibitors in children under 10 years of age with type 1 diabetes mellitus, an area that requires further research.Keywords: diabetic ketoacidosis, euglycemic diabetic ketoacidosis, pediatric diabetes, off-label drug use, type 1 diabetes mellitus, type 2 diabetes mellitus, adolescent diabetes care, adjunctive therapy, insulin therapy, sodium-glucose co-transporter 2 inhibitors |
|---|---|
| ISSN: | 1179-142X |